Regulation & Compliance

As supply chains fray, one manufacturer's move to bring filling in-house reveals a wider industry shift to protect margins and empower indie brands.

A new partnership promises to transform internal emails from simple memos into data-rich, engaging employee experiences that drive measurable impact.

With a key hire and a market shifting in its favor, the US futures giant is making a major play for Europe. Can it disrupt the established order?

Digital asset firm ReserveOne moves closer to a public debut via a SPAC deal, testing the waters for crypto companies in a shifting regulatory climate.

Lincoln Financial launches WealthProtector℠ IUL, a new policy aiming to meet rising consumer demand for financial products that blend safety and growth.

Ditching passive holding, Lite Strategy generated $600k from Litecoin options to fund buybacks. Is this the new playbook for corporate crypto finance?

A key Medtrade 2026 panel led by Synapse Health will unite industry leaders to chart the future of value-based care in the DME market.

New platform feature makes AI analysis fully traceable, tackling the 'black box' problem to build trust and accelerate high-stakes financial decisions.

GMAC's updated standards for business schools aim to demystify admissions data, recognizing new tests and clarifying GMAT and GPA reporting for applicants.

With a steady monthly dividend and a 7.8% yield, Apple Hospitality REIT offers income for investors. But what does it say about the hotel industry's health?

A new partnership tackles the exploding threat of non-human identities, aiming to govern the AI agents and bots now outnumbering humans in the enterprise.

A new survey shows 94% of IT leaders fear vendor lock-in, demanding practical AI and hybrid solutions over cloud-only hype. Is this the end of an era?

Amid rising demand, Sienna Senior Living expands its portfolio with key acquisitions in the GTA and Kelowna, consolidating its position in Canada's senior care sector.

Accord Healthcare's launch of generic lenalidomide signals a new era of affordability for a key cancer drug, intensifying competition and lowering costs.

The acquisition creates an end-to-end intelligence platform, combining institutional AI with alternative data to challenge generic models in finance.

A new collaborative is launching major health services, from maternal care to mental health, to address deep-seated disparities on Chicago's Far Southside.

A major patent deal shields Esperion's flagship drugs from generics, securing future revenue but delaying cheaper options for millions of patients.

Teamsters' national president and CA's Lt. Governor join striking CSU workers, accusing the university of unlawfully withholding contractually promised raises.

As deepfakes and synthetic identities surge, Aware, Inc. earns critical third-party certifications, proving its tech is secure, fair, and ready for reality.

Online casino Betty expands its Toronto footprint with new TFC and Argos partnerships, navigating a market defined by rapid growth and strict regulations.